NCT05263583 2025-01-14
Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
Cothera Bioscience, Inc
Phase 2 Active not recruiting
Clinical Trials
8 trialsNCT01007292 2015-10-19
A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
Astellas Pharma Inc
Phase 2 Completed
NCT00818480 2015-09-04
An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155
Astellas Pharma Inc
Phase 2 Completed
NCT01009775 2015-09-04
A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma
Astellas Pharma Inc
Phase 2 Completed
NCT01038804 2013-09-18
A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer
Astellas Pharma Inc
Phase 2 Completed
NCT00257478 2012-06-07
A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy
Astellas Pharma Inc
Phase 2 Completed
NCT00281541 2012-06-07
A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma
Astellas Pharma Inc
Phase 2 Completed
NCT00328588 2008-01-02
LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy
Astellas Pharma Inc
Phase 2 Completed